SCHEMBL19873467

SCHEMBL19873467

CN1CCCC1CCNc1nc(-c2ccc(C(Cl)(Cl)Cl)cc2)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACP1 P24666 2/20 0.40
▸ HRH2 P25021 2/20 0.39
▸ HRH1 P35367 2/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ CAMK2D Q13557 1/20 0.38
▸ NMT1 P30419 2/20 0.38
▸ KDM1A O60341 2/20 0.38
▸ BRAF P15056 1/20 0.37
▸ ACKR3 P25106 1/20 0.37
▸ CHRM3 P20309 3/20 0.36
▸ SLC22A1 O15245 1/20 0.36
▸ MLNR O43193 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ ADRB1 P08588 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16928030 0.94 CHRM3 (0.42) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL16928032 0.92 CAMK2D (0.44) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL16928575 0.92 KDM1A (0.45) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL16928309 0.91 ACP1 (0.47) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL16928348 0.91 CHRM3 (0.39) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL16928011 0.91 ACP1 (0.48) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL17721591 0.90 ACP1 (0.39) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL17721587 0.89 ACP1 (0.38) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL19873479 0.88 ACP1 (0.45) ACP1HRH2HRH1HRH3CAMK2D
SCHEMBL17721574 0.88 PTGS2 (0.39) ACP1HRH2HRH1HRH3CAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351538-A1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS The United States of America, as represented by The Secretary of The Army, on behalf of Walter Reed Army Institute of Research (US) 2018-07-25 — — EP disclosed
EP-2970153-B1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS THE US SECRETARY OF THE ARMY ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) 2018-02-21 — — EP disclosed
Send feedback